Intracellular ABC transporter A3 confers multidrug resistance in leukemia cells by lysosomal drug sequestration

Leukemia

Volumn 22, Issue 8, 2008, Pages 1576-1586

  Chapuy, B ^a   Koch, R ^a   Radunski, U ^a   Corsham, S ^a   Cheong, N ^b   Inagaki, N ^c   Ban, N ^d   Wenzel, D ^e   Reinhardt, D ^f   Zapf, A ^a   Schweyer, S ^a   Kosari, F ^g   Klapper, W ^g   Truemper, L ^a   Wulf, G G ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c KYOTO UNIVERSITY   (Japan)

^d AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e MAX PLANCK INSTITUTE FOR BIOPHYSICAL CHEMISTRY   (Germany)

^f HANNOVER MEDICAL SCHOOL   (Germany)

^g UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A3; CYTARABINE; CYTOSTATIC AGENT; DAUNORUBICIN; ETOPOSIDE; GEMTUZUMAB OZOGAMICIN; MITOXANTRONE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CELL MEMBRANE TRANSPORT; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG TRANSPORT; HEMATOPOIETIC TISSUE; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL LINE; LYSOSOME MEMBRANE; MAJOR CLINICAL STUDY; MEMBRANE VESICLE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TREATMENT RESPONSE;

EID: 49449110827     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2008.103     Document Type: Article

References (28)

1. Tallman MS, Gilliland DG, Rowe JM. Drug therapy for acute myeloid leukemia. Blood 2005; 106: 1154-1163.
2. Fialkow PJ, Gartler SM, Yoshida A. Clonal origin of chronic myelocytic leukemia in man. Proc Natl Acad Sci USA 1967; 58: 1468-1471.
3. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994; 367: 645-648.
4. Jordan CT, Guzman ML, Noble M. Cancer stem cells. N Engl J Med 2006; 355: 1253-1261.
5. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 1996; 183: 1797-1806.
6. Wulf GG, Wang RY, Kuehnle I, Weidner D, Marini F, Brenner MK et al A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia. Blood 2001; 98: 1166-1173.
7. Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax TW, Gobel U et al. A distinct 'side population' of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA 2004; 101 14228-14233.
8. Norwood K, Wang RY, Hirschmann-Jax C, Andreeff M, Brenner MK, Goodell MA et al. An in vivo propagated human acute myeloid leukemia expressing ABCA3. Leuk Res 2004; 28: 295-299.
9. Wulf GG, Modlich S, Inagaki N, Reinhardt D, Schroers R, Griesinger F et al. ABC transporter ABCA3 is expressed in acute myeloid leukemia blast cells and participates in vesicular transport. Haematologica 2004; 89: 1395-1397.
10. Cheong N, Madesh M, Gonzales LW, Zhao M, Yu K, Ballard PL et al. Functional and trafficking defects in ATP binding cassette A3 mutants associated with respiratory distress syndrome. J Biol Chem 2006; 281: 9791-9800.
11. Yamano G, Funahashi H, Kawanami O, Zhao LX, Ban N, Uchida Y et al. ABCA3 is a lamellar body membrane protein in human lung alveolar type II cells. FEBS Lett 2001; 508: 221-225.
12. Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1, 612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998; 92: 2322-2333.
13. Simon SM, Schindler M. Cell biological mechanisms of multidrug resistance in tumors. Proc Natl Acad Sci USA 1994; 91: 3497-3504.
14. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993; 62: 385-427.
15. Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 1976; 455: 152-162.
16. Marie JP, Zittoun R, Sikic BI. Multidrug resistance (mdr1) gene expression in adult acute leukemias: Correlations with treatment outcome and in vitro drug sensitivity. Blood 1991; 78: 586-592.
17. Leith CP, Kopecky KJ, Chen IM, Eijdems L, Slovak ML, McConnell TS et al. Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: A Southwest Oncology Group Study. Blood 1999; 94: 1086-1099.
18. Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992; 258: 1650-1654.
19. Hurwitz SJ, Terashima M, Mizunuma N, Slapak CA. Vesicular anthracycline accumulation in doxorubicin-selected U-937 cells: Participation of lysosomes. Blood 1997; 89: 3745-3754.
20. Altan N, Chen Y, Schindler M, Simon SM. Defective acidification in human breast tumor cells and implications for chemotherapy. J Exp Med 1998; 187: 1583-1598.
21. Klugbauer N, Hofmann F. Primary structure of a novel ABC transporter with a chromosomal localization on the band encoding the multidrug resistance-associated protein. FEBS Lett 1996; 391: 61-65.
22. Mulugeta S, Gray JM, Notarfrancesco KL, Gonzales LW, Koval M, Feinstein SI et al. Identification of LBM180, a lamellar body limiting membrane protein of alveolar type II cells, as the ABC transporter protein ABCA3. J Biol Chem 2002; 277: 22147-22155.
23. Shulenin S, Nogee LM, Annilo T, Wert SE, Whitsett JA, Dean M. ABCA3 gene mutations in newborns with fatal surfactant deficiency. N Engl J Med 2004; 350: 1296-1303.
24. Nagata K, Yamamoto A, Ban N, Tanaka AR, Matsuo M, Kioka N et al. Human ABCA3, a product of a responsible gene for abca3 for fatal surfactant deficiency in newborns, exhibits unique ATP hydrolysis activity and generates intracellular multilamellar vesicles. Biochem Biophys Res Commun 2004; 324: 262-268.
25. Yasui K, Mihara S, Zhao C, Okamoto H, Saito-Ohara F, Tomida A et al Alteration in copy numbers of genes as a mechanism for acquired drug resistance. Cancer Res 2004; 64: 1403-1410.
26. Efferth T, Gillet JP, Sauerbrey A, Zintl F, Bertholet V, de Longueville F et al. Expression profiling of ATP-binding cassette transporters in childhood T-cell acute lymphoblastic leukemia. Mol Cancer Ther 2006; 5: 1986-1994.
27. Steinbach D, Gillet JP, Sauerbrey A, Gruhn B, Dawczynski K, Bertholet V et al. ABCA3 as a possible cause of drug resistance in childhood acute myeloid leukemia. Clin Cancer Res 2006; 12: 4357-4363.
28. Stahlman MT, Besnard V, Wert SE, Weaver TE, Dingle S, Xu Y et al. Expression of ABCA3 in developing lung and other tissues. J Histochem Cytochem 2007; 55: 71-83.